Stratview Research has published a new report titled “Sepsis Diagnostics Market” which is segmented By Technology (Microbiology, Molecular Diagnostic, Immunoassay, and Biomarkers), By Type of Testing (Blood Culture Media, and Instruments), By Mode of Testing (Automated, Semi-Automated), By Site of Testing (Laboratory Based, Patient Bed Side (POC)), By Type of Sepsis (Pathogen) (Bacterial, Fungal), By Testing Facility (Hospitals, Clinics, and Others), By Region (North America, Western Europe, Asia-Pacific, Latin America, Rest of the World).
As per the study, Sepsis diagnostic has come a long way and its terminologies have changed many times. Currently, the majority of physicians follow the qSOFA guidelines published in 2016-2017. Some the physicians use SOFA score or SIRS criteria for the evaluation of sepsis. In spite of that, there is variation in diagnosis resulting in high cases of morbidity and mortality, there are many factors which are responsible for this, some of the important ones are an interpretation of test results & timely intervention, too much use of antibiotics – leading to multiple drug resistance, issues of test reproducibility (specificity and sensitivity) and also the availability of point of care/bedside testing and other infrastructural facilities in hospitals and clinics globally.
Report Highlights
This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the industry’s market dynamics. It provides a thorough analysis of the market segments which include products, applications, and competitor analysis.
The market is bifurcated into various segments. Below given is the segment-wise analysis -
However, in developed countries which are equipped with the latest facilities, there are reports of less number of sepsis cases. In a study of more than 7,000 patient outcomes, using the EarlySense System, the number of ICU days for transferred patients decreased by 46 percent, the overall hospital length of stay decreased by 9 percent in the intervention group, and the number of code-blue events decreased by 86 percent, all because patients were treated as soon as they began to deteriorate. The report published by Stratview Research covers all the latest technologies which are currently being used in various markets to diagnose sepsis.
The report also includes the forecast of the market, probable cases versus possible cases, import-export analysis, regulations – dos and don’t’s for the new player, growth forecast by segments such as pre-disposing factors, organisms, technology, and many more. The report identifies opportunities worth more than 40 Million USD in the market between the possible cases and actual cases diagnosed.
The research showcases that not only the Asia Pacific an attractive market, but Western Europe (CAGR 6.03%) also appears to be more lucrative than North America (5.52% CAGR 2019-2025). While microbiology and pathology as segments would be the most attractive growing at a CAGR of 10.5% between 2019-2025 closely followed by markers for sepsis.
Which Region is expected to remain the largest market?
Apart from major markets such as the USA, Germany, France, India, China, and Japan, potential markets such as Indonesia, South Africa, Russia, Canada, and Brazil have been studied in depth from the supplier and buyers’ point of view. The report gives a 360-degree overview for all the established players who would like to understand and compare a regional outlook of the sepsis diagnostic market.
Key questions answered by the report
What is the projected CAGR for revenue from the Sepsis Diagnostics Market during the forecast period?
What would the market be valued at by 2025?
What is a major driving factor for the growth of the market?
Which region accounted for the largest revenue share in the Sepsis Diagnostics Market?
Which are the major market players?
Custom Research:
Stratview Research delivers custom research services across sectors. In case of any custom research requirements, please send your inquiry to sales@stratviewresearch.com. Or connect with our experts at +1-313-307-4176.
About Us
Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision-making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.
